Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-019370

Chief Operating Officer bought 24,000 shares at an average $0.77 ($18,480)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cittadine Andrew Chief Operating Officer 2024-06-03 Purchase +12,000 $0.76 $9,120 105,624 D
Cittadine Andrew Chief Operating Officer 2024-06-04 Purchase +12,000 $0.78 $9,360 117,624 D
Open-market purchases · 24,000 sh · avg $0.77 · $18,480
Loading xslF345X05/rdgdoc.xml…